Santhi Gorantla
YOU?
Author Swipe
View article: The promise and perils of humanized mice: workshop report from the 29th scientific conference of the society on NeuroImmune pharmacology (SNIP)
The promise and perils of humanized mice: workshop report from the 29th scientific conference of the society on NeuroImmune pharmacology (SNIP) Open
On June 8, 2025, the 29th Scientific Conference of the Society on NeuroImmune Pharmacology (SNIP) hosted a workshop on the Creation, Care, and Translation of Humanized Mouse for HIV/AIDS Research . The workshop was convened by the society …
View article: Lymphoid and CXCR4 Cell Targeted Lipid Nanoparticles Facilitate HIV‐1 Proviral DNA Excision
Lymphoid and CXCR4 Cell Targeted Lipid Nanoparticles Facilitate HIV‐1 Proviral DNA Excision Open
Advancements in antiretroviral therapy (ART) enable those living with the human immunodeficiency virus type one (HIV‐1) to lead longer, healthier lives free from disease comorbidities. However, lifelong ART poses challenges. These include …
View article: CEST MRI Affirms HIV-1-Associated Neurometabolic Impairments in a Humanized Mouse Model
CEST MRI Affirms HIV-1-Associated Neurometabolic Impairments in a Humanized Mouse Model Open
View article: Abstract 2598 Modelling TET2-DNA Complex Formation
Abstract 2598 Modelling TET2-DNA Complex Formation Open
View article: Diastolic Dysfunction with Vascular Deficits in HIV-1-Infected Female Humanized Mice Treated with Antiretroviral Drugs
Diastolic Dysfunction with Vascular Deficits in HIV-1-Infected Female Humanized Mice Treated with Antiretroviral Drugs Open
Early-onset heart failure is a major treat to healthy aging individuals with HIV-1 infection. Women with HIV-1 infection (WLWH) are especially vulnerable and develop heart failure with preserved ejection fraction (HFpEF), of which left ven…
View article: Elevated Methylglyoxal: An Elusive Risk Factor Responsible for Early-Onset Cardiovascular Diseases in People Living with HIV-1 Infection
Elevated Methylglyoxal: An Elusive Risk Factor Responsible for Early-Onset Cardiovascular Diseases in People Living with HIV-1 Infection Open
People living with HIV (PLWH) develop cardiovascular diseases (CVDs) about a decade earlier and at rates 2–3 times higher than the general population. At present, pharmacological strategies to delay the onset of CVDs in PLWH are unavailabl…
View article: The 29th Scientific Conference of the Society on NeuroImmune Pharmacology in Omaha, NE, June 8–12, 2025
The 29th Scientific Conference of the Society on NeuroImmune Pharmacology in Omaha, NE, June 8–12, 2025 Open
The 29 th Scientific Conference of the Society on Neuroimmune Pharmacology (SNIP) in Omaha, NE, will occur from June 8 th to 11 th , 2025. This four-day conference showcases world-renowned biomedical research, providing insights into the l…
View article: HIV-1 infection facilitates Alzheimer’s disease pathology in humanized APP knock-in immunodeficient mice
HIV-1 infection facilitates Alzheimer’s disease pathology in humanized APP knock-in immunodeficient mice Open
Objectives Amyloid-β (Aβ) plaque deposition in the brain is a principal pathological feature of both Alzheimer’s disease (AD) and progressive human immunodeficiency virus type one (HIV-1) infection. Both enable Aβ assembly and Aβ protein a…
View article: CCR5-ligand decorated rilpivirine lipid-based nanoparticles for sustained antiretroviral responses
CCR5-ligand decorated rilpivirine lipid-based nanoparticles for sustained antiretroviral responses Open
View article: Lymphoid and CXCR4 Cell Targeted Lipid Nanoparticles Facilitate HIV-1 Proviral DNA Excision
Lymphoid and CXCR4 Cell Targeted Lipid Nanoparticles Facilitate HIV-1 Proviral DNA Excision Open
View article: Single-cell profiling reveals a conserved role for hypoxia-inducible factor signaling during human craniotomy infection
Single-cell profiling reveals a conserved role for hypoxia-inducible factor signaling during human craniotomy infection Open
View article: CCR5 Decorated Rilpivirine Lipid Nanoparticles Build Myeloid Drug Depots Which Sustains Antiretroviral Activities
CCR5 Decorated Rilpivirine Lipid Nanoparticles Build Myeloid Drug Depots Which Sustains Antiretroviral Activities Open
View article: Impaired extinction of cocaine seeking in HIV-infected mice is accompanied by peripheral and central immune dysregulation
Impaired extinction of cocaine seeking in HIV-infected mice is accompanied by peripheral and central immune dysregulation Open
View article: Accelerated Neuroimmune Dysfunction in Aged HIV-1-Infected Humanized Mice
Accelerated Neuroimmune Dysfunction in Aged HIV-1-Infected Humanized Mice Open
Disordered immunity, aging, human immunodeficiency virus type one (HIV-1) infection, and responses to antiretroviral therapy are linked. However, how each factor is linked with the other(s) remains incompletely understood. It has been repo…
View article: Impaired extinction of cocaine seeking in HIV-infected mice is accompanied by peripheral and central immune dysregulation
Impaired extinction of cocaine seeking in HIV-infected mice is accompanied by peripheral and central immune dysregulation Open
View article: Impaired extinction of cocaine seeking in HIV-infected mice is accompanied by peripheral and central immune dysregulation
Impaired extinction of cocaine seeking in HIV-infected mice is accompanied by peripheral and central immune dysregulation Open
Substance use disorders (SUDs) are highly comorbid with HIV infection, necessitating an understanding of the interactive effects of drug exposure and HIV. The relationship between progressive HIV infection and cocaine use disorder is likel…
View article: Humanized Mice for Studies of HIV-1 Persistence and Elimination
Humanized Mice for Studies of HIV-1 Persistence and Elimination Open
A major roadblock to achieving a cure for human immunodeficiency virus type one (HIV-1) is the persistence of latent viral infections in the cells and tissue compartments of an infected human host. Latent HIV-1 proviral DNA persists in res…
View article: The COVID-19 Pandemic: Reflections of Science, Person, and Challenge in Academic Research Settings
The COVID-19 Pandemic: Reflections of Science, Person, and Challenge in Academic Research Settings Open
In spring of 2021, the Society on NeuroImmune Pharmacology (SNIP) organized a virtual workshop on the coronavirus disease 2019 (COVID-19). The daylong event’s fourth and final symposium, “Well-being and reflections,” offered a glimpse at t…
View article: CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice
CRISPR editing of CCR5 and HIV-1 facilitates viral elimination in antiretroviral drug-suppressed virus-infected humanized mice Open
Treatment of HIV-1 ADA -infected CD34+ NSG-humanized mice with long-acting ester prodrugs of cabotegravir, lamivudine, and abacavir in combination with native rilpivirine was followed by dual CRISPR-Cas9 C-C chemokine receptor type five (C…
View article: Animal models for studies of HIV-1 brain reservoirs
Animal models for studies of HIV-1 brain reservoirs Open
The HIV-1 often evades a robust antiretroviral-mediated immune response, leading to persistent infection within anatomically privileged sites including the CNS. Continuous low-level infection occurs in the presence of effective antiretrovi…
View article: A Link Between Methylglyoxal and Heart Failure During HIV-1 Infection
A Link Between Methylglyoxal and Heart Failure During HIV-1 Infection Open
Early-onset heart failure (HF) continues to be a major cause of morbidity and mortality in people living with human immunodeficiency virus type one (HIV-1) infection (PLWH), yet the molecular causes for this remain poorly understood. Herei…
View article: The COVID-19 Pandemic: Reflections of Science, Person, and Challenge in Academic Research Settings
The COVID-19 Pandemic: Reflections of Science, Person, and Challenge in Academic Research Settings Open
View article: Editorial: Direct and Indirect Interactions of HIV With Host Cells
Editorial: Direct and Indirect Interactions of HIV With Host Cells Open
HIV causes AIDS by infection and depletion of CD4 + T cells. HIV can also infect other CD4 + cells 12 such as macrophages, possibly leading to their functional alterations and contribution to viral reservoirs 13 (Hendricks et al., 2021). O…
View article: Recovery of Latent HIV-1 from Brain Tissue by Adoptive Cell Transfer in Virally Suppressed Humanized Mice
Recovery of Latent HIV-1 from Brain Tissue by Adoptive Cell Transfer in Virally Suppressed Humanized Mice Open
View article: Humanized Mice for Infectious and Neurodegenerative disorders
Humanized Mice for Infectious and Neurodegenerative disorders Open
Humanized mice model human disease and as such are used commonly for research studies of infectious, degenerative and cancer disorders. Recent models also reflect hematopoiesis, natural immunity, neurobiology, and molecular pathways that i…
View article: Human Microglia Extensively Reconstitute in Humanized-BLT Mice With Human Interleukin-34 Transgene and Support HIV-1 Brain Infection
Human Microglia Extensively Reconstitute in Humanized-BLT Mice With Human Interleukin-34 Transgene and Support HIV-1 Brain Infection Open
Humanized bone marrow-liver-thymic (hu-BLT) mice develop a functional immune system in periphery, nevertheless, have a limited reconstitution of human myeloid cells, especially microglia, in CNS. Further, whether bone marrow derived hemato…
View article: Human microglia extensively reconstitute in humanized BLT mice with human interleukin-34 transgene and support HIV-1 brain infection
Human microglia extensively reconstitute in humanized BLT mice with human interleukin-34 transgene and support HIV-1 brain infection Open
Humanized bone marrow-liver-thymic (hu-BLT) mice develop a functional immune system in periphery but have a limited reconstitution of human myeloid cells, especially microglia, in CNS. Further, whether bone marrow derived hematopoietic ste…
View article: Diagnostics for SARS-CoV-2 infections
Diagnostics for SARS-CoV-2 infections Open
View article: Efavirenz, atazanavir, and ritonavir disrupt sarcoplasmic reticulum Ca2+ homeostasis in skeletal muscles
Efavirenz, atazanavir, and ritonavir disrupt sarcoplasmic reticulum Ca2+ homeostasis in skeletal muscles Open
View article: Pharmacotherapeutics of SARS-CoV-2 Infections
Pharmacotherapeutics of SARS-CoV-2 Infections Open